Top Markets
#1 EXOD EXOD +56.80%
#2 Glidr Glidr +35.02%
#3 Fabric Protocol Fabric Protocol +30.68%
#4 Nockchain Nockchain +19.84%
#5 Cysic Cysic +19.17%
#6 Bedrock Bedrock +18.72%
#7 Perle Perle +11.77%
#8 The Black Bull The Black Bull +10.40%
#9 FOLKS FOLKS +7.85%
#10 Epic Chain Epic Chain +7.11%
Coin of the day
EXOD EXOD
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Peak Bio, Inc. Peak Bio, Inc.

Peak Bio, Inc.

PKBO
Classifica tra le azioni #37553
Peak Bio, Inc. is a biopharmaceutical firm currently in the clinical... Peak Bio, Inc. is a biopharmaceutical firm currently in the clinical development phase, committed to devising treatments for critical, unmet medical needs in the realms of oncology and inflammatory disorders. The company harnesses its unique, proprietary toxin—known as PH-1 or Thailanstatin—a spliceosome modulator, to create its inaugural range of innovative Antibody-Drug Conjugate (ADC) therapies designed for cancer patients facing significant challenges. Additionally, Peak Bio's leading investigational drug, PHP-303, a small molecule, is on the verge of commencing a Phase II dose clinical trial for the rare condition Alpha1 anti-trypsin deficiency (AATD). The company's operations are situated in Palo Alto, California.
Prezzo delle azioni
$0.07
Ultima sincronizzazione: 2024-11-12
Capitalizzazione di mercato
$1.62M
Variazione (1 giorno)
0.00%
Variazione (1 anno)
0.00%
Paese
US
Scambia Peak Bio, Inc. (PKBO)

Categoria

Healthcare
Storico del prezzo dell'azione per Peak Bio, Inc. (PKBO)
Prezzo di chiusura più alto: $0.07 il 2024-11-01

Prezzo di chiusura più basso: $9.71 il 2021-03-01
Storico del prezzo dell'azione di Peak Bio, Inc. dal 2021 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2024 -26.66%
2023 -98.23%
2022 -44.81%
2021 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $505.24 28.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $846.09 29.41%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $731.69 6.47%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.82 11.75%
BE